Geode Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.65M | Buy |
1,326,123
+242,997
| +22% | +$1.04M | ﹤0.01% | 2667 |
|
|
2025
Q1 | $4.07M | Buy |
1,083,126
+156,964
| +17% | +$590K | ﹤0.01% | 2745 |
|
|
2024
Q4 | $5.4M | Sell |
926,162
-8,767
| -0.9% | -$51.1K | ﹤0.01% | 2710 |
|
|
2024
Q3 | $11.2M | Sell |
934,929
-125,170
| -12% | -$1.49M | ﹤0.01% | 2314 |
|
|
2024
Q2 | $11.5M | Buy |
1,060,099
+220,754
| +26% | +$2.39M | ﹤0.01% | 2239 |
|
|
2024
Q1 | $9.5M | Buy |
839,345
+14,512
| +2% | +$164K | ﹤0.01% | 2353 |
|
|
2023
Q4 | $11.6M | Buy |
824,833
+169,079
| +26% | +$2.37M | ﹤0.01% | 2251 |
|
|
2023
Q3 | $8.1M | Buy |
655,754
+48,414
| +8% | +$598K | ﹤0.01% | 2386 |
|
|
2023
Q2 | $5.48M | Buy |
607,340
+257,394
| +74% | +$2.32M | ﹤0.01% | 2629 |
|
|
2023
Q1 | $1.21M | Buy |
349,946
+13,047
| +4% | +$45.3K | ﹤0.01% | 3256 |
|
|
2022
Q4 | $825K | Buy |
336,899
+9,364
| +3% | +$22.9K | ﹤0.01% | 3446 |
|
|
2022
Q3 | $903K | Buy |
327,535
+40,288
| +14% | +$111K | ﹤0.01% | 3439 |
|
|
2022
Q2 | $1.17M | Sell |
287,247
-187,651
| -40% | -$764K | ﹤0.01% | 3353 |
|
|
2022
Q1 | $2.02M | Buy |
474,898
+14,537
| +3% | +$61.9K | ﹤0.01% | 3248 |
|
|
2021
Q4 | $4.31M | Sell |
460,361
-4,926
| -1% | -$46.1K | ﹤0.01% | 2978 |
|
|
2021
Q3 | $12.8M | Buy |
465,287
+252,765
| +119% | +$6.97M | ﹤0.01% | 2281 |
|
|
2021
Q2 | $5.95M | Sell |
212,522
-1,701
| -0.8% | -$47.6K | ﹤0.01% | 2799 |
|
|
2021
Q1 | $7.11M | Buy |
214,223
+187,725
| +708% | +$6.23M | ﹤0.01% | 2598 |
|
|
2020
Q4 | $1.27M | Buy |
+26,498
| New | +$1.27M | ﹤0.01% | 3284 |
|